Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

One-year cardiovascular event rates in outpatients with atherothrombosis.

Steg PG, Bhatt DL, Wilson PW, D'Agostino R Sr, Ohman EM, Röther J, Liau CS, Hirsch AT, Mas JL, Ikeda Y, Pencina MJ, Goto S; REACH Registry Investigators.

JAMA. 2007 Mar 21;297(11):1197-206.

PMID:
17374814
2.

Atherothrombosis and the management of the vulnerable vascular patient.

Arora R, Rai F.

Am J Ther. 2009 Jan-Feb;16(1):24-34. doi: 10.1097/MJT.0b013e318032587d. Review.

PMID:
19114877
3.
4.

The Burden of Major Adverse Cardiac Events and Antiplatelet Prevention in Patients with Coronary or Peripheral Arterial Disease.

Khoury H, Lavoie L, Welner S, Folkerts K.

Cardiovasc Ther. 2016 Apr;34(2):115-24. doi: 10.1111/1755-5922.12169. Review.

PMID:
26670723
5.

The Emerging Epidemic of Cardiovascular Risk Factors and Atherosclerotic Disease in Developing Countries.

Teo KK, Dokainish H.

Can J Cardiol. 2017 Mar;33(3):358-365. doi: 10.1016/j.cjca.2016.12.014. Epub 2016 Dec 24. Review.

PMID:
28232018
6.

Antithrombotic therapy for secondary prevention of atherothrombotic events in cerebrovascular disease.

Capodanno D, Alberts M, Angiolillo DJ.

Nat Rev Cardiol. 2016 Oct;13(10):609-22. doi: 10.1038/nrcardio.2016.111. Epub 2016 Aug 4. Review.

PMID:
27489191
7.

Hypercoagulability Is a Stronger Risk Factor for Ischaemic Stroke than for Myocardial Infarction: A Systematic Review.

Maino A, Rosendaal FR, Algra A, Peyvandi F, Siegerink B.

PLoS One. 2015 Aug 7;10(8):e0133523. doi: 10.1371/journal.pone.0133523. eCollection 2015. Review.

8.

Endothelial function as a functional expression of cardiovascular risk factors.

Reriani MK, Lerman LO, Lerman A.

Biomark Med. 2010 Jun;4(3):351-60. doi: 10.2217/bmm.10.61. Review.

Supplemental Content

Support Center